Evidence map›Paper›PMID 26906939›Full record

ArticleTransplantation2016

Silencing Porcine CMAH and GGTA1 Genes Significantly Reduces Xenogeneic Consumption of Human Platelets by Porcine Livers.

James Russell Butler, Leela L Paris, Ross L Blankenship, Richard A Sidner, Gregory R Martens, Joseph M Ladowski, Ping Li, Jose L Estrada, Matthew Tector, A Joseph Tector

Open access · greenAbstract read
In one paragraph

Article in Transplantation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. CRISPR/Cas Technology in Pig-to-Human Xenotransplantation Research.International journal of molecular sciences · 2021
    Review
  6. Review
  7. Article
  8. Review
  9. [Research progress of producing genetically modified pigs by CRISPR/Cas9 in the medical field].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2018
    Review
  10. Xenotransplantation: past, present, and future.Current opinion in organ transplantation · 2017
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 3 countries.

James Russell Butler1 Department of Surgery, Indiana University School of Medicine, Indianapolis, IN.
Leela L Paris
Ross L Blankenship
Richard A Sidner
Gregory R Martens
Joseph M Ladowski
Ping Li
Jose L Estrada
Matthew Tector
A Joseph Tector
Apple (Israel) · IL

Funding

EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR010601 · NCRR · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MERRITT, DORIS H. · 1994 to 1994
–
NCRR NIH HHS C06 RR010601NCRR NIH HHS C06RR10601-01
6 · The paper itself

Abstract

backgroundA profound thrombocytopenia limits hepatic xenotransplantation in the pig-to-primate model. Porcine livers also have shown the ability to phagocytose human platelets in the absence of immune-mediated injury. Recently, inactivation of the porcine ASGR1 gene has been shown to decrease this phenomenon. Inactivating GGTA1 and CMAH genes has reduced the antibody-mediated barrier to xenotransplantation; herein, we describe the effect that these modifications have on xenogeneic consumption of human platelets in the absence of immune-mediated graft injury.

methodsWild type (WT), ASGR1, GGTA1, and GGTA1CMAH knockout pigs were compared for their xenogeneic hepatic consumption of human platelets. An in vitro assay was established to measure the association of human platelets with liver sinusoidal endothelial cells (LSECs) by immunohistochemistry. Perfusion models were used to measure human platelet uptake in livers from WT, ASGR1, GGTA1, and GGTA1 CMAH pigs.

resultsGGTA1, CMAH LSECs exhibited reduced levels of human platelet binding in vitro when compared with GGTA1 and WT LSECs. In a continuous perfusion model, GGTA1 CMAH livers consumed fewer human platelets than GGTA1 and WT livers. GGTA1 CMAH livers also consumed fewer human platelets than ASGR1 livers in a single-pass model.

conclusionsSilencing the porcine carbohydrate genes necessary to avoid antibody-mediated rejection in a pig-to-human model also reduces the xenogeneic consumption of human platelets by the porcine liver. The combination of these genetic modifications may be an effective strategy to limit the thrombocytopenia associated with pig-to-human hepatic xenotransplantation.

Indexed as

PhagocytosisAnimalsAnimals, Genetically ModifiedAntibodies, HeterophileAntigens, HeterophileAsialoglycoprotein ReceptorBlood PlateletsCells, CulturedGalactosyltransferasesGraft RejectionGraft SurvivalHeterograftsHumansLiverMixed Function OxygenasesPlatelet Adhesivenessalpha-1,3-galactosyltransferase 1, porcineAntibodies, HeterophileAntigens, HeterophileAsialoglycoprotein ReceptorCMPacetylneuraminate monooxygenaseGalactosyltransferasesMixed Function Oxygenases

Identifiers

PMID26906939
PMCPMC4770806
OpenAlexW2283408896

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.